Gilead Sciences Other Current Liability (Quarterly) Analysis

Gilead Sciences, Inc. (GILD)

149.89 -1.51 (-1.00%) USD | NASDAQ | Feb 23, 11:42

View Other Current Liability (Quarterly) for GILD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Current Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Current Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Current Liability (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Johnson & Johnson	--
Eli Lilly & Co.	Upgrade
Regeneron Pharmaceuticals, Inc.	--
Moderna, Inc.	Upgrade